Abstracts Archive - Page 550 of 1683 - ATC Abstracts

2020 American Transplant Congress
Absence of Adverse Infectious Disease Outcomes in the Long-Term Follow-Up of Recipients of PHS Increased Risk Donor Organs: An Essential Tracking Program
L. Irwin, J. Fishman
Transplant Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: 37-41% of deceased donors in Region I are considered “PHS increased risk for infectious disease transmission” (IR) individuals, our Center developed guidelines for the…
2020 American Transplant Congress
A Survey of Lung Transplant Recipient Attitudes and Beliefs on Accepting an Organ That Was Positive for Hepatitis C Virus
S. S. Humar¹, N. Pinzon¹, M. Cypel¹, S. Abbey²
¹University Health Network, Transplant Center, Toronto, ON, Canada, ²University Health Network, Center for Mental Health, Toronto, ON, Canada
*Purpose: Recent data show that organs from donors who are HCV positive (+ve) can be safely transplanted into HCV negative recipients. We conducted a survey…
2020 American Transplant Congress
Anticipated Cost Savings of Using Lungs from Hepatitis C-Positive Lung Donors for Hepatitis C-Negative Recipients
K. Ryland¹, J. Mallea², J. Moriarty³, L. White⁴, B. Borah⁵, J. Naessens³
¹Transplantation, Mayo Clinic, Jacksonville, FL, ²Medicine, Mayo Clinic, Jacksonville, FL, ³Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research, Mayo Clinic, Jacksonville, FL, ⁵Health Sciences Research, Mayo Clinic, Rochester, MN
*Purpose: We assessed the cost savings generated by additional organ availability due to utilizing lungs from hepatitis-C infected donors for transplantation in comparison to existing…
2020 American Transplant Congress
Distance and Community Characteristics are Associated with Waitlist Mortality Prior to Lung Transplantation
H. Hoy, W. Gannon, S. Rega, J. Karp, E. Lambright, E. Gillaspie, M. Bacchetta, I. Feurer
Vanderbilt Medical Center, Nashville, TN
*Purpose: While specific clinical characteristics known to impact lung transplant waitlist mortality and proximity to the transplant center have been associated with outcomes in other…
2020 American Transplant Congress
Did the 250 Nautical Mile Circle Work? Geographic Disparities in Lung Transplantation Before and after the Policy Change
M. Kosztowski¹, Y. Yu², A. Massie², D. L. Segev², S. E. Gentry²
¹University of Iowa, Iowa City, IA, ²Johns Hopkins, Baltimore, MD
*Purpose: In November 2017, the lung allocation policy was challenged in court due to concern that candidates living in New York City were being disadvantaged…
2020 American Transplant Congress
Risk Aversion in Lung Transplantation: Organ Procurement Organizations Differ in Willingness to Pursue Non-Ideal Donor Organs
S. E. Halpern¹, A. McConnell², S. Peskoe², V. Raman³, O. K. Jawitz³, A. Y. Choi¹, J. C. Haney³, J. A. Klapper³, M. G. Hartwig³
¹Duke University School of Medicine, Durham, NC, ²Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, ³Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: Lungs from non-ideal deceased donors are disproportionally discarded despite evidence that waitlisted candidates benefit from use of these organs. Organ procurement organizations (OPOs) individually…
2020 American Transplant Congress
Calculating the Lung Allocation Score Error for ECMO Patients
N. Dussault¹, J. Katsis², E. Garrity¹, M. M. Churpek³, W. F. Parker¹
¹University of Chicago, Chicago, IL, ²Vanderbilt University, Nashville, TN, ³University of Wisconsin, Madision, WI
*Purpose: The use of extracorporeal membranous oxygenation (ECMO) as a bridge to lung transplantation has increased dramatically. However, the Lung Allocation Score (LAS) does not…
2020 American Transplant Congress
Outcomes of Simultaneous Pancreas-Kidney vs. Kidney Alone Transplants in Type 2 Diabetic Recipients: A Multivariate Analysis of U.S. Transplants
S. M. Riad¹, S. Jackson², D. Keys¹, V. Humphereville³, L. Caramori¹, R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: The impact of simultaneous pancreas-kidney (SPK) transplants in uremic, non-obese, insulin-treated type 2 diabetic (T2DM) recipients is not well described. We analyzed the SRTR…
2020 American Transplant Congress
Impact of Functional Status on Outcomes of Simultaneous Pancreas-Kidney Transplantation: Risks and Opportunities for Patient Benefit
K. Lentine¹, T. Alhamad², M. Cooper³, Z. Zhang⁴, K. Woodside⁵, D. Dadhania⁶, S. Chang², D. Axelrod⁷, M. Schnitzler⁴, R. Ouseph¹, J. Snyder⁸, B. Kasiske⁸, R. Parsons⁹
¹Department of Medicine, Saint Louis University, Saint Louis, MO, ²Washington Univ, Seattle, WA, ³Georgetown Univ, Washington, DC, ⁴Saint Louis University, Saint Louis, MO, ⁵Univ of Michigan, Ann Arbor, MI, ⁶Weill Cornell, New York, NY, ⁷Univ of Iowa, Iowa City, IA, ⁸SRTR, Minneapolis, MN, ⁹Emory, Atlanta, GA
*Purpose: The impact of functional status on survival among simultaneous pancreas-kidney transplant (SPKT) candidates and recipients is not well described.*Methods: We examined national Scientific Registry…
2020 American Transplant Congress
Outcome of and Risk Factor for Pancreas Transplants with Marginal Donors
A. Gruessner, S. Saggi, J. Renz, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Over the years, the selection criteria for a pancreas donor changed with the decline in numbers of transplants. More and more younger donors with…